2.86 USD
-0.02 (-0.69%)
2.8976 USD
+0.04 (+1.31%)
Taking everything into account, GDRX scores 6 out of 10 in our fundamental rating. GDRX was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of GDRX get a neutral evaluation. Nothing too spectacular is happening here. GDRX is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make GDRX suitable for value investing!
1. Profitability
1.1 Basic Checks
- GDRX had positive earnings in the past year.
- In the past year GDRX had a positive cash flow from operations.
- GDRX had negative earnings in 4 of the past 5 years.
- In the past 5 years GDRX always reported a positive cash flow from operatings.
1.2 Ratios
- GDRX has a Return On Assets of 2.40%. This is amongst the best in the industry. GDRX outperforms 85.71% of its industry peers.
- GDRX has a Return On Equity of 5.29%. This is amongst the best in the industry. GDRX outperforms 91.43% of its industry peers.
- The Return On Invested Capital of GDRX (5.73%) is better than 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROIC | 5.73% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 3.97%, GDRX belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
- GDRX's Profit Margin has declined in the last couple of years.
- With an excellent Operating Margin value of 10.37%, GDRX belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
- In the last couple of years the Operating Margin of GDRX has declined.
- GDRX's Gross Margin of 93.46% is amongst the best of the industry. GDRX outperforms 100.00% of its industry peers.
- GDRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GDRX is destroying value.
- GDRX has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, GDRX has about the same amount of shares outstanding.
- The debt/assets ratio for GDRX has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 0.47, we must say that GDRX is in the distress zone and has some risk of bankruptcy.
- GDRX has a Altman-Z score (0.47) which is in line with its industry peers.
- The Debt to FCF ratio of GDRX is 4.66, which is a neutral value as it means it would take GDRX, 4.66 years of fcf income to pay off all of its debts.
- GDRX's Debt to FCF ratio of 4.66 is in line compared to the rest of the industry. GDRX outperforms 60.00% of its industry peers.
- A Debt/Equity ratio of 0.81 indicates that GDRX is somewhat dependend on debt financing.
- GDRX's Debt to Equity ratio of 0.81 is on the low side compared to the rest of the industry. GDRX is outperformed by 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Altman-Z | 0.47 |
ROIC/WACC0.55
WACC10.51%
2.3 Liquidity
- GDRX has a Current Ratio of 3.11. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
- GDRX has a better Current ratio (3.11) than 62.86% of its industry peers.
- A Quick Ratio of 3.11 indicates that GDRX has no problem at all paying its short term obligations.
- GDRX has a better Quick ratio (3.11) than 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 9.37% over the past year.
- GDRX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.47% yearly.
- GDRX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.30%.
- Measured over the past years, GDRX shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
3.2 Future
- GDRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.32% yearly.
- The Revenue is expected to grow by 5.00% on average over the next years.
EPS Next Y11.45%
EPS Next 2Y16.13%
EPS Next 3Y16.77%
EPS Next 5Y25.32%
Revenue Next Year0.19%
Revenue Next 2Y1.53%
Revenue Next 3Y3.35%
Revenue Next 5Y5%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 8.17, the valuation of GDRX can be described as very reasonable.
- Based on the Price/Earnings ratio, GDRX is valued cheaper than 100.00% of the companies in the same industry.
- GDRX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
- With a Price/Forward Earnings ratio of 6.43, the valuation of GDRX can be described as very cheap.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 100.00% of the companies listed in the same industry.
- GDRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.17 | ||
| Fwd PE | 6.43 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 94.29% of the companies listed in the same industry.
- GDRX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GDRX is cheaper than 91.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.25 | ||
| EV/EBITDA | 7.23 |
4.3 Compensation for Growth
- GDRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- GDRX has a very decent profitability rating, which may justify a higher PE ratio.
- GDRX's earnings are expected to grow with 16.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.71
PEG (5Y)N/A
EPS Next 2Y16.13%
EPS Next 3Y16.77%
5. Dividend
5.1 Amount
- No dividends for GDRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
2.86
-0.02 (-0.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners50.75%
Inst Owner Change0.01%
Ins Owners11.19%
Ins Owner Change3.28%
Market Cap970.77M
Revenue(TTM)800.65M
Net Income(TTM)31.75M
Analysts74.29
Price Target4.98 (74.13%)
Short Float %8.84%
Short Ratio3.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.02%
Min EPS beat(2)-13.38%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.95%
Min EPS beat(4)-13.38%
Max EPS beat(4)-7.12%
EPS beat(8)2
Avg EPS beat(8)-4.79%
EPS beat(12)6
Avg EPS beat(12)4.06%
EPS beat(16)9
Avg EPS beat(16)11.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.22%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.22%
Revenue beat(8)0
Avg Revenue beat(8)-1.92%
Revenue beat(12)1
Avg Revenue beat(12)-1.83%
Revenue beat(16)2
Avg Revenue beat(16)-1.59%
PT rev (1m)-4.05%
PT rev (3m)-8.19%
EPS NQ rev (1m)0.74%
EPS NQ rev (3m)-4.06%
EPS NY rev (1m)0.19%
EPS NY rev (3m)-3.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.38%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.17 | ||
| Fwd PE | 6.43 | ||
| P/S | 1.21 | ||
| P/FCF | 9.25 | ||
| P/OCF | 5.4 | ||
| P/B | 1.62 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.23 |
EPS(TTM)0.35
EY12.24%
EPS(NY)0.45
Fwd EY15.56%
FCF(TTM)0.31
FCFY10.81%
OCF(TTM)0.53
OCFY18.52%
SpS2.36
BVpS1.77
TBVpS-0.08
PEG (NY)0.71
PEG (5Y)N/A
Graham Number3.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROCE | 7.26% | ||
| ROIC | 5.73% | ||
| ROICexc | 7.53% | ||
| ROICexgc | 26.92% | ||
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% | ||
| FCFM | 13.11% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y37.95%
ROICexgc growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score6
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Debt/EBITDA | 2.95 | ||
| Cap/Depr | 92.2% | ||
| Cap/Sales | 9.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 109.5% | ||
| Profit Quality | 330.43% | ||
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 | ||
| Altman-Z | 0.47 |
F-Score6
WACC10.51%
ROIC/WACC0.55
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
EPS Next Y11.45%
EPS Next 2Y16.13%
EPS Next 3Y16.77%
EPS Next 5Y25.32%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
Revenue Next Year0.19%
Revenue Next 2Y1.53%
Revenue Next 3Y3.35%
Revenue Next 5Y5%
EBIT growth 1Y179.68%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year34.43%
EBIT Next 3Y15.99%
EBIT Next 5Y13.87%
FCF growth 1Y9.18%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y16.5%
OCF growth 3Y0.94%
OCF growth 5Y17.16%
GOODRX HOLDINGS INC-CLASS A / GDRX FAQ
Can you provide the ChartMill fundamental rating for GOODRX HOLDINGS INC-CLASS A?
ChartMill assigns a fundamental rating of 6 / 10 to GDRX.
What is the valuation status for GDRX stock?
ChartMill assigns a valuation rating of 9 / 10 to GOODRX HOLDINGS INC-CLASS A (GDRX). This can be considered as Undervalued.
What is the profitability of GDRX stock?
GOODRX HOLDINGS INC-CLASS A (GDRX) has a profitability rating of 6 / 10.
What is the earnings growth outlook for GOODRX HOLDINGS INC-CLASS A?
The Earnings per Share (EPS) of GOODRX HOLDINGS INC-CLASS A (GDRX) is expected to grow by 11.45% in the next year.